COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohortResearch Published on 2021-11-012022-10-28 Journal: BMC Nephrology [Category] COVID-19, MERS, SARS, [키워드] 30-Day mortality 95%CI acute kidney AKI analysed Cohort COVID-19 demonstrated diagnosis of COVID-19 discharge Epidemiology exhibited gradually increased hazard ratio higher risk hospital hospitalised incidence incidence rate increased mortality Inpatient Kidney injury laboratory-confirmed London Mortality outcome Patient patients with COVID-19 reducing renal function renal impairment renal replacement therapy required Result risk risk factor RRT Stage study period supplementary material survivor Survivors with COVID-19 worse prognosis [DOI] 10.1186/s12882-021-02557-x PMC 바로가기 [Article Type] Research
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19COVID-19 예방을 위한 Ad26.COV2.S 아데노바이러스 벡터 백신의 효과 분석Article Published on 2021-11-012022-09-11 Journal: JAMA Network Open [Category] SARS, 변종, 신약개발, [키워드] 95% CI Ad26 Ad26.COV2.S Ad26.COV2.S vaccine age Alpha amplify build Chain Reaction Cohort cohorts composed Continuous COV2.S COVID-19 Critical Delta dose drug Drug administration effective Effectiveness Efficacy effort Electronic health record Electronic health records Ethnicity evaluate Final food Health identify IMPROVE incidence rate individuals Johnson & Johnson mass vaccination Mayo Clinic men outcome outcomes Patient patients polymerase chain polymerase chain reaction Polymerase chain reaction testing Preventing Propensity score rate ratio reducing reduction in Research Retrospective analysis SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccine Sex single dose Spread study cohort System the vaccine Transparency vaccination variant variants vector ZIP Code [DOI] 10.1001/jamanetworkopen.2021.32540 PMC 바로가기 [Article Type] Article
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project이탈리아의 분산 다중 데이터베이스 의료 네트워크를 통한 면역 매개 염증성 질환에 대한 생물학적 약물의 대규모 시판 후 감시: The VALORE 프로젝트Article Published on 2021-11-012022-09-12 Journal: BioDrugs : clinical immunotherapeutics, biopharmac [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome adverse event age Analysis approved association Biological biological drug biological drugs calculated Compound conducted coronavirus cumulative database drug event Follow-up Frequency highest Immune-mediated inflammatory disease incidence rate Inclusion Infection infections inhibitor investigated Italian Italian region Italian regions lowest malignancy management moderate Necrosis offer outcome outcomes Patient power calculation Prevalence provide Region required retrospective cohort study Severe infection Standard deviation Statistical power stratified Surveillance therapeutic TNFα [DOI] 10.1007/s40259-021-00498-3 PMC 바로가기 [Article Type] Article
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort브라질 마나우스의 2차 유행 이전 높은 항 SARS-CoV-2 항체 혈청 전환율 및 사회적 행동 조치의 보호 효과: 전향적 DETECTCoV-19 코호트의 결과Article Published on 2021-11-012022-09-11 Journal: The Lancet. Global health [Category] MERS, SARS, 진단, 치료법, [키워드] 95% CI adjusted analyses Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody association Asymptomatic baseline Brazil calculated city Cohort Comorbidities Compliance Contact contact with COVID-19 COVID-19 case COVID-19 diagnosis COVID-19 pandemic criteria defined disease status education event first visit flu-like symptom flu-like symptoms Follow-up follow-up period had no Health Health Organization health system house household IgG antibody implementation in-house ELISA incidence incidence rate Increased increased the risk Infection transmission information Intervention IQR Mask measure Measures median negative control nucleocapsid optical optical density organization Pan participant physical distancing Poisson regression model positive proportion Protective Protective behaviours protective effect rate ratios reactivity recruited Relaxation reported returned risk factor Risk factors second wave separated Seroconversion seroconversion rate seronegative seropositive serum Sociodemographic characteristics study cohort study period symptomatic Symptoms the epidemic Transmission variable was measured website were excluded with COVID-19 [DOI] 10.1016/S2214-109X(21)00355-7 PMC 바로가기 [Article Type] Article
Does the data tell the true story? A modelling assessment of early COVID-19 pandemic suppression and mitigation strategies in GhanaResearch Article Published on 2021-10-292022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] available data basic reproduction number bootstrap China COVID-19 infection COVID-19 pandemic COVID-19 transmission disease early phase Effectiveness estimate Europe General population Government growth incidence rate infected individual initial Isolation MONITOR Mortality outbreak pandemic parameter progression public health public health measure quarantine reduce reduced reported Reproduction number risk of transmission severe disease statistical model Time to recovery Treatment vaccination virus mutations [DOI] 10.1371/journal.pone.0258164 PMC 바로가기 [Article Type] Research Article
Community‐based differentiated service delivery models incorporating multi‐month dispensing of antiretroviral treatment for newly stable people living with HIV receiving single annual clinical visits: a pooled analysis of two cluster‐randomized trials in southern Africa매년 단일 임상 방문을 받는 HIV에 감염된 새로 안정된 사람들을 위한 항레트로바이러스 치료의 수개월 분배를 통합하는 지역 사회 기반의 차별화된 서비스 제공 모델: 남아프리카의 2건의 클러스터 무작위 시험에 대한 통합 분석Meta-Analysis Published on 2021-10-282022-09-10 Journal: Journal of the International AIDS Society [Category] MERS, SARS, 임상, 치료제, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted Analysis antiretroviral antiretroviral treatment ARMS ART CAG Care Clinic visits clinical cluster‐randomized trial Clustering Community conducted coronavirus country COVID‐19 decrease differentiated service delivery Effectiveness enrolled enrolment Evidence exposure to Frequency group Health healthcare healthcare facility HIV treatment incidence rate include Intervention intervention arms limit margin multi‐month dispensing not increased operational research participant Primary outcome provided rate ratio receiving regression analysis respiratory Result retained retention risk risk difference risk ratio secondary outcome Secondary outcomes severe acute respiratory syndrome Coronavirus SOC Treatment Trial Viral visit frequency with HIV Zimbabwe [DOI] 10.1002/jia2.25819 PMC 바로가기 [Article Type] Meta-Analysis
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine TypesArticle Published on 2021-10-282022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] 95% CI Ad26.COV2.S Administered administration Adults Adverse age approach BNT162b2 Coronavirus disease-19 COVID-19 COVID-19 vaccination COVID-19 vaccine dose event high risk incidence incidence rate increased risk inequality janssen Messenger RNA mRNA mRNA COVID-19 vaccines mRNA vaccine mRNA-1273 Myocardial myocarditis Odds ratio Patient Pericarditis reported Reporting risk second dose significantly System the United State Type vaccination Vaccine Vaccines Viral vector vaccine was performed [DOI] 10.3390/jpm11111106 PMC 바로가기 [Article Type] Article
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 PandemicCOVID-19 팬데믹 기간 동안 신장 이식 수혜자의 항흉선세포 글로불린 사용 안전성Article Published on 2021-10-262022-09-12 Journal: Annals of transplantation [Category] MERS, 진단, [키워드] administration adverse effect adverse event analyzed antithymocyte appear Blood comparable COVID-19 COVID-19 pandemic cumulative dose Globulin Graft incidence rate infectious complication Infectious complications kidney kidney transplant recipient lymphocyte median outcome pandemic Patient patients patients treated protocol recipient risk Safe Safety therapy treated Treatment [DOI] 10.12659/AOT.933001 PMC 바로가기 [Article Type] Article
Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis인도 오디샤 주의 SARS-CoV-2 전파 역학 분석: 1년 동안의 탐색적 데이터 분석Article Published on 2021-10-252022-09-10 Journal: International Journal of Environmental Research an [Category] MERS, SARS, 변종, [키워드] age Analysis association average cause chose conducted confirmed case confirmed cases Coronavirus infection COVID-19 Critical dataset datasets death death rates demographic characteristics Dynamics Effect environmental factor environmental factors epidemiological epidemiological surveillance Factor Gender global public health incidence rate incidence rates India lesson Local matter multivariate New York Occurrence pandemic pattern persistence population density population-based studies predict prevention Relative risk reported Research risk Risk assessment SARS-CoV-2 SARS-CoV-2 transmission second wave Sex sex ratio Spread state suggested Surveillance temperature temperature effect timeline USA variant variants Viral Viral transmission [DOI] 10.3390/ijerph182111203 PMC 바로가기 [Article Type] Article
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infectionArticle Published on 2021-10-252022-10-04 Journal: Nature Medicine [Category] MERS, SARS, 유전자 메커니즘, 치료기술, 치료법, [키워드] 95% confidence interval Analysis association Bell’s palsy BNT162b2 case sery Cohort Complication COVID-19 vaccine COVID-19 vaccines England first dose greater Guillain–Barrè syndrome Hemorrhagic Stroke higher risk highlight Hospital admission incidence rate increased risk independent Infection neurological Neurological complication Neurological disorders neuroscience outcome positive provided public health receiving Regulatory risk SARS-COV-2 infection SARS-CoV-2 test Scottish Support vaccination Vaccinations with COVID-19 [DOI] 10.1038/s41591-021-01556-7 PMC 바로가기 [Article Type] Article